Two genes in the transforming growth factor-beta (TGF-β) signaling pathway, ENG and ACVRL1, were discovered almost two decades ago, and mutations in these genes have been reported to cause up to 85% of HHT. This evidence concerns the gene TGFB1 and hereditary hemorrhagic telangiectasia.